TSU and SPbSRIVS will engineer a new generation of vaccines
2021-07-14
Tomsk State University and St. Petersburg Research Institute of Vaccines and Serums are discussing creating a consortium to conduct joint research.
The idea is to create a platform for a new generation of vaccines that can be easily updated to combat new threats. TSU is also developing bachelor’s, master’s, and doctoral programs to provide the partner institution with skilled employees.
Read more: https://en.tsu.ru/news/tsu-and-spbsrivs-will-engineer-a-new-generation-of-vaccines/
The idea is to create a platform for a new generation of vaccines that can be easily updated to combat new threats. TSU is also developing bachelor’s, master’s, and doctoral programs to provide the partner institution with skilled employees.
“To effectively protect people from the most dangerous pathogens, we need vaccines that can be updated fast,” TSU Vice-Rector for Research and Innovation Aleeksand Vorozhtsov says. “There are four categories of vaccines: inactivated and recombinant are well-known, while vector and mRNA vaccines are something newer. When a pathogen mutates fast, it is important to have a vaccine that can be quickly modified. That is why we are collaborating with our partner, a leading national enterprise, to create a platform for new-generation vaccines..”
Read more: https://en.tsu.ru/news/tsu-and-spbsrivs-will-engineer-a-new-generation-of-vaccines/
